Sign in
MANE Stock Price, Chart, Stats & News
Veradermics, Incorporated
Save
3.92B
Market cap
–
Current P/E
–
Forward P/E
MANE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -44.61% |
ROE | -76.46% |
D/E | – |
Interest coverage ratio | -45.77x |
MANE valuation
P/E | – |
P/S | – |
P/B | 241.35x |
P/CF | -556.97x |
P/FCF | -97.04x |
P/OCF | -556.97x |
PEG | -4.98x |
EV multiple | -90.79x |
About
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics. A flagship offering is VDPHL01, an orally administered, non-hormonal medication specifically for chronic hair loss management in both male and female patients with PHL.
Similar securities
Based on sector and market capitalization
Report issue